thiazolyl blue has been researched along with gossypol in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Coyle, T; Levante, S; Shetler, M; Winfield, J | 1 |
| Bauer, JA; Bradford, CR; Carey, TE; Fisher, SG; Ji, M; Narayan, A; O'Connell, KM; Oliver, CL; Ubell, ML; Wang, S; Wolter, KG; Wu, X | 1 |
| Jia, G; Wu, D; Xu, L; Xu, Y; Zhan, Y | 1 |
| An, QX; Chen, R; Huang, XF; Mu, SJ; Wu, DC; Xia, AJ; Zhang, XQ | 1 |
4 other study(ies) available for thiazolyl blue and gossypol
| Article | Year |
|---|---|
In vitro and in vivo cytotoxicity of gossypol against central nervous system tumor cell lines.
Topics: Animals; Antineoplastic Agents; Cell Line; Cell Survival; Central Nervous System Neoplasms; Glioma; Gossypol; Humans; Isoenzymes; L-Lactate Dehydrogenase; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Rats; Tetrazolium Salts; Thiazoles; Transplantation, Heterologous; Tumor Cells, Cultured | 1994 |
In vitro effects of the BH3 mimetic, (-)-gossypol, on head and neck squamous cell carcinoma cells.
Topics: Apoptosis; bcl-X Protein; Blotting, Western; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dimerization; Dose-Response Relationship, Drug; Drug Resistance; Fibroblasts; Gossypol; Head and Neck Neoplasms; Humans; In Situ Nick-End Labeling; Inhibitory Concentration 50; Peptide Fragments; Protein Structure, Tertiary; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Tetrazolium Salts; Thiazoles; Time Factors; Tumor Suppressor Protein p53 | 2004 |
Design and synthesis of a gossypol derivative with improved antitumor activities.
Topics: Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Colony-Forming Units Assay; Drug Screening Assays, Antitumor; Gossypol; Humans; Indicators and Reagents; Models, Molecular; Tetrazolium Salts; Thiazoles | 2009 |
Inhibition of proliferation of prostate cancer cell line, PC-3, in vitro and in vivo using (-)-gossypol.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Apoptosis; Biomarkers, Tumor; Cell Line, Tumor; Cell Proliferation; Cell Survival; Contraceptive Agents, Male; Gossypol; Humans; In Situ Nick-End Labeling; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Microvessels; Microvilli; Neovascularization, Pathologic; Platelet Endothelial Cell Adhesion Molecule-1; Proliferating Cell Nuclear Antigen; Prostatic Neoplasms; Proto-Oncogene Proteins c-bcl-2; Tetrazolium Salts; Thiazoles; Xenograft Model Antitumor Assays | 2010 |